Endometrial pathologies associated with postmenopausal tamoxifen treatment

Keyphrases

• Tamoxifen Therapy 100%
• Endometrial Pathology 100%
• Endometrial Cancer 40%
• Endometrial Polyp 40%
• Randomized Clinical Trial 20%
• Gynaecological Symptoms 20%
• Polyps 20%
• Case-controlled Study 20%
• Patient Experience 20%
• Clinical Aspects 20%
• Advanced Stage 20%
• Retrospective Case 20%
• Sarcoma 20%
• Diagnosis Stage 20%
• Gynecologic Malignancies 20%
• Pelvic Pain 20%
• Malignancy Rate 20%
• Unfavorable Histology 20%
• Endometrial Hyperplasia 20%
• Postmenopausal Breast Cancer 20%
• Malignant Mixed Mesodermal Tumor 20%
• Endometrial Stromal Sarcoma 20%
• Pelvic Pressure 20%
• Randomized Cohort Studies 20%

Medicine and Dentistry

• Tamoxifen 100%
• Cancer 33%
• Uterine Cancer 33%
• Endometrial Polyp 33%
• Clinical Feature 16%
• Clinician 16%
• Breast Cancer 16%
• Polyp 16%
• Prospective Cohort Study 16%
• Randomized Clinical Trial 16%
• Mixed Tumor 16%
• Patient Experience 16%
• Pelvic Pain 16%
• Endometrial Hyperplasia 16%
• Endometrial Stromal Sarcoma 16%
• Connective Tissue Cancer 16%
• Minimal Effective Dose 16%